Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/brainsci11030305 http://scihub22266oqcxt.onion/10.3390/brainsci11030305 33673697!7997244!33673697     free     free     free       Brain+Sci 2021 ; 11 (3): ä Nephropedia Template TP {{tp|p=33673697|t=2021. COVID-19 and Alzheimer s Disease |pdf=|usr=}}{{33673697}} gab.com Text COVID-19 and Alzheimer s Disease JO: Brain Sci http://www.kidney.de/pget.php?&tw=1&pmid=33673697 #FOAvip The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer's Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to be more prone to developing AD. On the other hand, AD patients could be more susceptible to severe COVID-19. In this review, we sought to provide an overview on the relationship between AD and COVID-19, focusing on the potential role of biomarkers, which could represent precious tool for early identification of COVID-19 patients at high risk of developing AD. Twit Text FOAVip COVID-19 and Alzheimer s Disease ????Brain Sci http://www.kidney.de/pget.php?&tw=1&pmid=33673697 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33673697 #FOAvip English Wikipedia <ref>{{Cite pmid|33673697}}</ref> COVID-19 and Alzheimer s Disease #MMPMID33673697 Ciaccio M; Lo Sasso B; Scazzone C; Gambino CM; Ciaccio AM; Bivona G; Piccoli T; Giglio RV; Agnello L Brain Sci 2021[Feb]; 11 (3): ä PMID33673697show ga The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer's Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to be more prone to developing AD. On the other hand, AD patients could be more susceptible to severe COVID-19. In this review, we sought to provide an overview on the relationship between AD and COVID-19, focusing on the potential role of biomarkers, which could represent precious tool for early identification of COVID-19 patients at high risk of developing AD. äCOVID-19 and Alzheimer s Disease (epmc).pdf DeepDyve Pubget Overpricing